- Home
- VYX vs BCRX Comparison
VYX vs BCRX Comparison
Compare VYX & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYX
- BCRX
- Stock Information
- Founded
- VYX 1881
- BCRX 1986
- Country
- VYX United States
- BCRX United States
- Employees
- VYX N/A
- BCRX N/A
- Industry
- VYX
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VYX
- BCRX Health Care
- Exchange
- VYX Nasdaq
- BCRX Nasdaq
- Market Cap
- VYX 2.0B
- BCRX 1.7B
- IPO Year
- VYX N/A
- BCRX 1994
- Fundamental
- Price
- VYX $13.96
- BCRX $7.03
- Analyst Decision
- VYX Strong Buy
- BCRX Buy
- Analyst Count
- VYX 7
- BCRX 6
- Target Price
- VYX $16.33
- BCRX $14.67
- AVG Volume (30 Days)
- VYX 1.3M
- BCRX 2.5M
- Earning Date
- VYX 11-07-2024
- BCRX 11-04-2024
- Dividend Yield
- VYX N/A
- BCRX N/A
- EPS Growth
- VYX N/A
- BCRX N/A
- EPS
- VYX 4.40
- BCRX N/A
- Revenue
- VYX $3,592,000,000.00
- BCRX $412,579,000.00
- Revenue This Year
- VYX N/A
- BCRX $37.24
- Revenue Next Year
- VYX N/A
- BCRX $19.30
- P/E Ratio
- VYX $3.21
- BCRX N/A
- Revenue Growth
- VYX 956.47
- BCRX 29.92
- 52 Week Low
- VYX $10.87
- BCRX $4.03
- 52 Week High
- VYX $17.39
- BCRX $8.88
- Technical
- Relative Strength Index (RSI)
- VYX 55.79
- BCRX 40.38
- Support Level
- VYX $13.96
- BCRX $6.85
- Resistance Level
- VYX $14.70
- BCRX $8.25
- Average True Range (ATR)
- VYX 0.48
- BCRX 0.46
- MACD
- VYX 0.10
- BCRX -0.08
- Stochastic Oscillator
- VYX 65.19
- BCRX 11.32
About VYX NCR Voyix Corporation
NCR Voyix Corp is a company providing services of digital commerce solutions for retail, restaurant, and digital banking. The company operates in three reportable segments: Retail, Restaurants, and Digital Banking. The Retail segment provides software solutions for retailers of all sizes, enhancing operational efficiency and customer experience. The Restaurants segment offers end-to-end technology solutions for food service establishments, improving operational efficiency, and customer satisfaction, and reducing costs. The Digital Banking segment serves financial institutions with cloud-based software solutions for a fully integrated digital banking experience across channels. Revenue sources include software sales and service support within each segment.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.